Article
A targetable epigenetic vulnerability in PI3K/AKT inhibitor resistant cancers
medRxiv · 2020 · Di Wu
Key facts
| Title | A targetable epigenetic vulnerability in PI3K/AKT inhibitor resistant cancers |
|---|---|
| First author | Di Wu |
| Journal | medRxiv |
| Published | Aug 28, 2020 |
| DOI | 10.1101/2020.08.27.269613 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K973350, K990827 |
| Product codes mentioned | JCI, JJH, KIP, KIT, MVU, NDS, NJT, OOI, PFT, JLX, KQP, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1